Results 151 to 160 of about 1,555 (179)
Some of the next articles are maybe not open access.

Immunosuppression by Gramicidin S of Experimental Autoimmune Uveoretinitis, Pinealitis and Autoimmune Encephalomyelitis

Journal of Ocular Pharmacology and Therapeutics, 1990
Using an in vitro lymphocyte proliferation assay we screened several cyclic peptide antibiotics (bacitracin, oleandomycin, capreomycin, colistin, virginiamycin, and gramicidin S) for their immunosuppressive activity. Gramicidin S (GrS) was found to inhibit [3H]-thymidine incorporation into concanavalin A-stimulated and E coli lipopolysaccharide ...
S, Matsushima, T, Yoshitoshi, H, Shichi
openaire   +2 more sources

Genetic factors in susceptibility and resistance to experimental autoimmune uveoretinitis

Current Eye Research, 1992
Experimental autoimmune uveoretinitis (EAU) can be induced in susceptible stains of rats and mice by immunization with purified retinal antigens, and serves as a model for human uveitis. Because strong HLA associations have been noted in a number of human uveitic diseases, we investigated the role of major histocompatibility complex (MHC) vs.
R R, Caspi   +8 more
openaire   +2 more sources

Experimental autoimmune uveoretinitis: idiotypic regulation and disease suppression

International Ophthalmology, 1990
Experimental autoimmune uveoretinitis (EAU), a mostly T-cell dependent disease, was induced in laboratory animals by a single immunization with retinal extract or purified S-antigen in complete Freund's adjuvant. It can be prevented or suppressed by injections of either the autoantigen or monoclonal antibodies against the autoantigen.
Y, De Kozak, M, Mirshahi
openaire   +2 more sources

Tacrolimus-rapamycin combination therapy for experimental autoimmune uveoretinitis

Japanese Journal of Ophthalmology, 1997
Tacrolimus and rapamycin both belong to a new family of immunosuppressants, immunophilin ligands, but the mechanisms by which they inhibit T cell activation are different. Therefore, we tested the immunosuppressive effects of combination therapy with low doses of tacrolimus and rapamycin on experimental autoimmune uveoretinitis (EAU) in rats.
E, Ikeda   +3 more
openaire   +2 more sources

Evidence for immediate hypersensitivity phenomena in experimental autoimmune uveoretinitis

European Journal of Immunology, 1981
AbstractEvidence is presented for the involvement of immediate hypersensitivity phenomena in experimental autoimmune uveoretinitis, an ocular inflammatory disease induced in Lewis rats by injection of the purified S antigen from bovine retina. Several parameters at various dates after immunization have been studied.
Y, de Kozak   +3 more
openaire   +2 more sources

The dissection of experimental autoimmune uveoretinitis

Immunology Today, 1990
Shigeaki Ohno, Naoki Kumagai
openaire   +1 more source

T-lymphocyte and experimental autoimmune uveoretinitis.

Japanese journal of ophthalmology, 1987
The immunopathogenic mechanisms underlying S-antigen-induced experimental autoimmune uveoretinitis (EAU) were discussed with particular emphasis on the cellular immune response on the basis of the following data: 1) athymic nude rats did not develop EAU unless sensitized lymphocytes obtained from heterozygous rats were transferred into the nude rats; 2)
openaire   +1 more source

Experimental autoimmune uveoretinitis

1996
Igal Gery   +2 more
openaire   +1 more source

In vivo lymphokine production in experimental autoimmune uveoretinitis.

Immunology, 1993
Experimental autoimmune uveoretinitis (EAU) is a well-characterized model of immune-mediated intraocular inflammation. The intraocular infiltrate in EAU consists predominantly of T lymphocytes. The in vivo production of interleukin-2 (IL-2), lymphotoxin and IL-4 by these T cells was investigated by in situ hybridization using cDNA probes to lymphokine ...
D G, Charteris, S L, Lightman
openaire   +1 more source

Idiotypic vaccination of experimental autoimmune uveoretinitis

Journal of Autoimmunity, 1992
Y. de Kozak   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy